Dr. Martin Hessner, PhD has discovered that type 1 diabetes patients during the honeymoon phase
create a unique genomic fingerprint. His research team in Milwaukee found that this fingerprint is
evident years prior to the actual onset of disease.
This discovery is highly significant because it offers insight into the pathways responsible for type 1 diabetes. Other therapeutics have been found to be successful in prolonging the honeymoon phase and may help delay (or even prevent) the onset of "full blown" diabetes - when used in conjuction with these findings our hope of stopping this disease upon detection comes closer to reality.
The study was recently published in The Journal of Immunology.